i

i&i Prague

9 employees

i&i Prague is a bio-innovation center partner for biotech innovations and smart money investments.

Investor insights

Sectors invested in

Biotechnology3
Life Science2
Pharmaceutical2
Health Care2
Drug Discovery1
PPI1
Geometric Deep Learning1
Protein-Protein-Interaction1
PROTAC1
Drug Builder1
Molecular glue1
Graph Neural Networks1
Deep Learning1
Artificial Intelligence1
Drug Design1
Protein-Ligand Interaction1
Protein1
Information Technology1
Medical1
protein-protein interaction1

Funding rounds participated in

$2.7M sweet spot round size

Most of their 4 investments are in rounds between $250K and $3.4M

Investor type

Accelerator

Basic info

Industry

biotechnology research

Sectors

Medical Science
Technology Transfer Office
Technology Transfer
Investor
Biotech incubator
Medical Diagnostics

Date founded

2017

Investments made

C

Celeris Therapeutics raised $3.4M on February 10, 2022

Investors: Pace Ventures, Longevitytech.fund, R42 Group and i&i Prague

P

PEP-Therapy raised $1.9M on July 19, 2021

Investors: Anaxago and i&i Prague

E

Elphogene, s.r.o. raised $250K on April 5, 2019

Investors: i&i Prague

D

Dracen Pharmaceuticals, Inc. raised $40M on March 22, 2018

Investors: Osage University Partners (OUP) and i&i Prague

FAQ